BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-82. [PMID: 16423888 DOI: 10.1136/gut.2005.082701] [Cited by in Crossref: 116] [Cited by in F6Publishing: 115] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Kawada N. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease. Gut. 2006;55:1073-1074. [PMID: 16849344 DOI: 10.1136/gut.2005.090449] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
2 Cannito S, Novo E, Compagnone A, Valfrè di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, Cravanzola C, Bravoco V, Colombatto S, Parola M. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008;29:2267-78. [PMID: 18791199 DOI: 10.1093/carcin/bgn216] [Cited by in Crossref: 216] [Cited by in F6Publishing: 202] [Article Influence: 16.6] [Reference Citation Analysis]
3 Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: Concept to treatment. J Hepatol. 2015;62:S15-24. [PMID: 25920084 DOI: 10.1016/j.jhep.2015.02.039] [Cited by in Crossref: 350] [Cited by in F6Publishing: 328] [Article Influence: 70.0] [Reference Citation Analysis]
4 Kuehl T, Lagares D. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts. Matrix Biol 2018;68-69:94-105. [PMID: 29408011 DOI: 10.1016/j.matbio.2018.01.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
5 Wang S, Friedman SL. Hepatic fibrosis: A convergent response to liver injury that is reversible. J Hepatol 2020;73:210-1. [PMID: 32402525 DOI: 10.1016/j.jhep.2020.03.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
6 Kirovski G, Gäbele E, Dorn C, Moleda L, Niessen C, Weiss TS, Wobser H, Schacherer D, Buechler C, Wasmuth HE, Hellerbrand C. Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. Int J Clin Exp Pathol 2010;3:675-80. [PMID: 20830238 [PMID: 20830238 DOI: 10.1055/s-0029-1246351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Monument MJ, Hart DA, Salo PT, Befus AD, Hildebrand KA. Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions. Adv Wound Care (New Rochelle) 2015;4:137-51. [PMID: 25785237 DOI: 10.1089/wound.2013.0509] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
8 Novo E, Cannito S, Paternostro C, Bocca C, Miglietta A, Parola M. Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys. 2014;548:20-37. [PMID: 24631571 DOI: 10.1016/j.abb.2014.02.015] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 17.3] [Reference Citation Analysis]
9 Li J, Li X, Xu W, Wang S, Hu Z, Zhang Q, Deng X, Wang J, Zhang J, Guo C. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways. Liver Int 2015;35:1222-33. [DOI: 10.1111/liv.12638] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
10 Cheng Y, Ping J, Xu L. Effects of curcumin on peroxisome proliferator-activated receptor γ expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells: . Chinese Medical Journal 2007;120:794-801. [DOI: 10.1097/00029330-200705010-00011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
11 Tian H, Liu L, Li Z, Liu W, Sun Z, Xu Y, Wang S, Liang C, Hai Y, Feng Q, Zhao Y, Hu Y, Peng J. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. Journal of Ethnopharmacology 2019;232:227-35. [DOI: 10.1016/j.jep.2018.11.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Guo CJ, Pan Q, Jiang B, Chen GY, Li DG. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis. 2009;14:1331-1340. [PMID: 19784778 DOI: : 10.1007/s10495-009-0401-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Park JS, Oh Y, Park YJ, Park O, Yang H, Slania S, Hummers LK, Shah AA, An HT, Jang J, Horton MR, Shin J, Dietz HC, Song E, Na DH, Park EJ, Kim K, Lee KC, Roschke VV, Hanes J, Pomper MG, Lee S. Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma. Nat Commun 2019;10:1128. [PMID: 30850660 DOI: 10.1038/s41467-019-09101-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
14 Son MK, Ryu YL, Jung KH, Lee H, Lee HS, Yan HH, Park HJ, Ryu JK, Suh JK, Hong S, Hong SS. HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Sci Rep 2013;3:3470. [PMID: 24326778 DOI: 10.1038/srep03470] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
15 Zhang Z, Lin C, Peng L, Ouyang Y, Cao Y, Wang J, Friedman SL, Guo J. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells. Life Sci 2012;91:207-12. [PMID: 22841886 DOI: 10.1016/j.lfs.2012.07.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
16 Teng KY, Barajas JM, Hu P, Jacob ST, Ghoshal K. Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice. Biology (Basel) 2020;9:E157. [PMID: 32650615 DOI: 10.3390/biology9070157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu Y, Wang Z, Kwong SQ, Lui EL, Friedman SL, Li FR, Lam RW, Zhang GC, Zhang H, Ye T. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol. 2011;55:612-625. [PMID: 21251937 DOI: 10.1016/j.jhep.2010.11.035] [Cited by in Crossref: 116] [Cited by in F6Publishing: 123] [Article Influence: 11.6] [Reference Citation Analysis]
18 Lemieszek MK, Ribeiro M, Guichard Alves H, Marques G, Nunes FM, Rzeski W. Boletus edulis ribonucleic acid – a potent apoptosis inducer in human colon adenocarcinoma cells. Food Funct 2016;7:3163-75. [DOI: 10.1039/c6fo00132g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Lotersztajn S, Prieto J, Berasain C, Avila MA. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology 2008;48:1251-61. [PMID: 18634036 DOI: 10.1002/hep.22437] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 6.7] [Reference Citation Analysis]
20 Oakley F, Teoh V, Ching-A-Sue G, Bataller R, Colmenero J, Jonsson JR, Eliopoulos AG, Watson MR, Manas D, Mann DA. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 2009;136:2334-2344.e1. [PMID: 19303015 DOI: 10.1053/j.gastro.2009.02.081] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 6.8] [Reference Citation Analysis]
21 Narváez CF, Franco MA, Angel J, Morton JM, Greenberg HB. Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin. J Virol 2010;84:4543-55. [PMID: 20164228 DOI: 10.1128/JVI.02550-09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
22 Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol. 2009;50:766-778. [PMID: 19232449 DOI: 10.1016/j.jhep.2008.11.025] [Cited by in Crossref: 207] [Cited by in F6Publishing: 213] [Article Influence: 17.3] [Reference Citation Analysis]
23 Wang R, Zhang H, Wang Y, Song F, Yuan Y. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling. Int Immunopharmacol 2017;47:126-33. [PMID: 28391159 DOI: 10.1016/j.intimp.2017.03.029] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 14.3] [Reference Citation Analysis]
24 Tashiro K, Satoh A, Utsumi T, Chung C, Iwakiri Y. Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice. Am J Pathol 2013;182:786-95. [PMID: 23313137 DOI: 10.1016/j.ajpath.2012.11.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
25 Huang Y, Deng X, Liang J. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res. 2017;352:420-426. [PMID: 28238836 DOI: 10.1016/j.yexcr.2017.02.038] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
26 Cheng CF, Pan TM. Ankaflavin and Monascin Induce Apoptosis in Activated Hepatic Stellate Cells through Suppression of the Akt/NF-κB/p38 Signaling Pathway. J Agric Food Chem 2016;64:9326-34. [PMID: 27960292 DOI: 10.1021/acs.jafc.6b03700] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
27 Pinzani M. Unraveling the spider web of hepatic stellate cell apoptosis. Gastroenterology 2009;136:2061-3. [PMID: 19416764 DOI: 10.1053/j.gastro.2009.04.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
28 Stefano JT, Cogliati B, Santos F, Lima VM, Mazo DC, Matte U, Alvares-da-Silva MR, Silveira TR, Carrilho FJ, Oliveira CP. S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro. Nitric Oxide 2011;25:360-5. [PMID: 21820071 DOI: 10.1016/j.niox.2011.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
29 Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007;315:1853-6. [PMID: 17395831 DOI: 10.1126/science.1137603] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 8.6] [Reference Citation Analysis]
30 Xu P, Zhang Y, Liu Y, Yuan Q, Song L, Liu M, Liu Z, Yang Y, Li J, Li D, Ren G. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways. Toxicol Appl Pharmacol 2016;290:43-53. [PMID: 26592322 DOI: 10.1016/j.taap.2015.11.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
31 Nakano Y, Kamiya A, Sumiyoshi H, Tsuruya K, Kagawa T, Inagaki Y. A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice. Hepatology 2020;71:1437-52. [PMID: 31549421 DOI: 10.1002/hep.30965] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
32 Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med. 2011;3:69-80. [PMID: 24367223 DOI: 10.2147/hmer.s9051] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
33 Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility - molecular mechanisms. Clin Liver Dis. 2008;12:915-937, xi. [PMID: 18984474 DOI: 10.1016/j.cld.2008.07.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
34 Ogawa T, Kawada N, Ikeda K. Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells. Hepatol Int 2009;3:497-503. [PMID: 19669254 DOI: 10.1007/s12072-009-9129-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
35 Douglass A, Wallace K, Parr R, Park J, Durward E, Broadbent I, Barelle C, Porter AJ, Wright MC. Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. Journal of Hepatology 2008;49:88-98. [DOI: 10.1016/j.jhep.2008.01.032] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
36 Huang G, Wang Y, Wang J, Yang C, Huang T, Zhuang Z, Gu J. A morphologic and semi-quantitative technique to analyze synthesis and release of specific proteins in cells. BMC Cell Biol 2014;15:45. [PMID: 25476158 DOI: 10.1186/s12860-014-0045-1] [Reference Citation Analysis]
37 Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 2010;53:132-144. [PMID: 20447716 DOI: 10.1016/j.jhep.2010.02.027] [Cited by in Crossref: 159] [Cited by in F6Publishing: 156] [Article Influence: 14.5] [Reference Citation Analysis]
38 Jameel NM, Thirunavukkarasu C, Wu T, Watkins SC, Friedman SL, Gandhi CR. p38-MAPK- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by retinoic acid. J Cell Physiol. 2009;218:157-166. [PMID: 18792915 DOI: 10.1002/jcp.21581] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
39 Kahraman A, Mott JL, Bronk SF, Werneburg NW, Barreyro FJ, Guicciardi ME, Akazawa Y, Braley K, Craig RW, Gores GJ. Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse. Dig Dis Sci. 2009;54:1908-1917. [PMID: 19051025 DOI: 10.1007/s10620-008-0583-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
40 Novo E, Busletta C, Bonzo LVD, Povero D, Paternostro C, Mareschi K, Ferrero I, David E, Bertolani C, Caligiuri A, Cannito S, Tamagno E, Compagnone A, Colombatto S, Marra F, Fagioli F, Pinzani M, Parola M. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. Journal of Hepatology 2011;54:964-74. [DOI: 10.1016/j.jhep.2010.09.022] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
41 Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Fisher A, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun 2019;10:6. [PMID: 30602778 DOI: 10.1038/s41467-018-07858-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 31.5] [Reference Citation Analysis]
42 Lu L, Wang J, Lu H, Zhang G, Liu Y, Wang J, Zhang Y, Shang H, Ji H, Chen X, Duan Y, Li Y. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study. Biochem Biophys Res Commun 2015;465:387-93. [PMID: 26255201 DOI: 10.1016/j.bbrc.2015.08.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
43 席文娜, 孙水林, 李方春, 罗杰, 肖影群, 章萍, 张伟. α-2a干扰素对大鼠肝组织bcl-2基因表达的影响及意义. 世界华人消化杂志 2009; 17(31): 3237-3240 [DOI: 10.11569/wcjd.v17.i31.3237] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Nakamura A, Ueno T, Yagi Y, Okuda K, Ogata T, Nakamura T, Torimura T, Iwamoto H, Ramadoss S, Sata M, Tsutsumi V, Yasuda K, Tomiyasu Y, Obayashi K, Tashiro K, Kuhara S. Human primary cultured hepatic stellate cells can be cryopreserved. Med Mol Morphol 2010;43:107-15. [PMID: 20683699 DOI: 10.1007/s00795-009-0484-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
45 Zhang X, Han X, Yin L, Xu L, Qi Y, Xu Y, Sun H, Lin Y, Liu K, Peng J. Potent effects of dioscin against liver fibrosis. Sci Rep. 2015;5:9713. [PMID: 25853178 DOI: 10.1038/srep09713] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
46 Sharma S, Ghufran SM, Das B, Roy B, Ghose S, Biswas S. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury. Life Sci 2021;287:120119. [PMID: 34743004 DOI: 10.1016/j.lfs.2021.120119] [Reference Citation Analysis]
47 Wang Z, Li J, Xiao W, Long J, Zhang H. The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis. Lab Invest 2018;98:1600-13. [DOI: 10.1038/s41374-018-0127-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
48 Wu D, Rao Q, Chen W, Ji F, Xie Z, Huang K, Chen E, Zhao Y, Ouyang X, Zhang S, Jiang Z, Zhang L, Xu L, Gao H, Li L. Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B. Liver Int 2018;38:1930-9. [DOI: 10.1111/liv.13756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, Friedman SL. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 2009;49:960-968. [PMID: 19085953 DOI: 10.1002/hep.22697] [Cited by in Crossref: 147] [Cited by in F6Publishing: 148] [Article Influence: 12.3] [Reference Citation Analysis]
50 Park KC, Park JH, Jeon JY, Kim SY, Kim JM, Lim CY, Lee TH, Kim HK, Lee HG, Kim SM, Kwon HJ, Suh JS, Kim SW, Choi SH. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells. Br J Pharmacol 2014;171:4820-30. [PMID: 24467283 DOI: 10.1111/bph.12590] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
51 Hasegawa D, Wallace MC, Friedman SL. Stellate Cells and Hepatic Fibrosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 41-62. [DOI: 10.1016/b978-0-12-800134-9.00004-x] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
52 Johnson A, DiPietro LA. Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J. 2013;27:3893-3901. [PMID: 23783074 DOI: 10.1096/fj.12-214189] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 10.1] [Reference Citation Analysis]
53 [DOI: 10.1101/2019.12.23.886259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 González-puertos VY, Hernández-pérez E, Nuño-lámbarri N, Ventura-gallegos JL, López-diázguerrero NE, Robles-díaz G, Gutiérrez-ruiz MC, Konigsberg M. Bcl-2 overexpression in hepatic stellate cell line CFSC-2G, induces a pro-fibrotic state: Bcl-2 overexpression induces a pro-fobrogenic state. Journal of Gastroenterology and Hepatology 2010;25:1306-14. [DOI: 10.1111/j.1440-1746.2009.06175.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
55 Busletta C, Novo E, Valfrè Di Bonzo L, Povero D, Paternostro C, Ievolella M, Mareschi K, Ferrero I, Cannito S, Compagnone A, Bandino A, Colombatto S, Fagioli F, Parola M. Dissection of the Biphasic Nature of Hypoxia-Induced Motogenic Action in Bone Marrow-Derived Human Mesenchymal Stem Cells. STEM CELLS 2011;29:952-63. [DOI: 10.1002/stem.642] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
56 Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25:281-290. [PMID: 21497745 DOI: 10.1016/j.bpg.2011.02.009] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 11.4] [Reference Citation Analysis]
57 Watson MR, Wallace K, Gieling RG, Manas DM, Jaffray E, Hay RT, Mann DA, Oakley F. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J Hepatol. 2008;48:589-597. [PMID: 18279996 DOI: 10.1016/j.jhep.2007.12.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
58 Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008;1:5. [PMID: 19014652 DOI: 10.1186/1755-1536-1-5] [Cited by in Crossref: 246] [Cited by in F6Publishing: 210] [Article Influence: 18.9] [Reference Citation Analysis]
59 Kirovski G, Dorn C, Huber H, Moleda L, Niessen C, Wobser H, Schacherer D, Buechler C, Wiest R, Hellerbrand C. Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation. Exp Mol Pathol. 2011;91:780-783. [PMID: 21855538 DOI: 10.1016/j.yexmp.2011.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
60 Sun X, Huang X, Zhu X, Liu L, Mo S, Wang H, Wei X, Lu S, Bai F, Wang D, Lin X, Lin J. HBOA ameliorates CCl4-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways. Biomed Pharmacother 2019;115:108901. [PMID: 31079002 DOI: 10.1016/j.biopha.2019.108901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Schrader J, Fallowfield J, Iredale JP. Senescence of activated stellate cells: not just early retirement. Hepatology 2009;49:1045-7. [PMID: 19242970 DOI: 10.1002/hep.22832] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
62 Li Q, Yan Z, Li F, Lu W, Wang J, Guo C. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells. Nanotechnology. 2012;23:265101. [PMID: 22700686 DOI: 10.1088/0957-4484/23/26/265101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
63 Siegmund SV, Schlosser M, Schildberg FA, Seki E, De Minicis S, Uchinami H, Kuntzen C, Knolle PA, Strassburg CP, Schwabe RF. Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells. PLoS One. 2016;11:e0150893. [PMID: 26937641 DOI: 10.1371/journal.pone.0150893] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
64 Parola M, Marra F, Pinzani M. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. Mol Aspects Med. 2008;29:58-66. [PMID: 18022682 DOI: 10.1016/j.mam.2007.09.002] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 8.2] [Reference Citation Analysis]
65 Jiang JX, Mikami K, Venugopal S, Li Y, Török NJ. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 2009;51:139-48. [PMID: 19457567 DOI: 10.1016/j.jhep.2009.03.024] [Cited by in Crossref: 107] [Cited by in F6Publishing: 106] [Article Influence: 8.9] [Reference Citation Analysis]
66 He L, Hou X, Fan F, Wu H. Quercetin stimulates mitochondrial apoptosis dependent on activation of endoplasmic reticulum stress in hepatic stellate cells. Pharm Biol 2016;54:3237-43. [PMID: 27572285 DOI: 10.1080/13880209.2016.1223143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
67 Cannito S, Novo E, Parola M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev 2017;121:57-84. [PMID: 28578015 DOI: 10.1016/j.addr.2017.05.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
68 Gonzalez SA, Fiel MI, Sauk J, Canchis PW, Liu RC, Chiriboga L, Yee HT, Jacobson IM, Talal AH. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat 2009;16:141-8. [PMID: 19175868 DOI: 10.1111/j.1365-2893.2008.01052.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
69 Myung SJ, Yoon JH, Kim BH, Lee JH, Jung EU, Lee HS. Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells. J Pharmacol Exp Ther 2009;330:276-82. [PMID: 19329756 DOI: 10.1124/jpet.109.151860] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
70 Chakraborty JB, Oakley F, Walsh MJ. Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. Int J Hepatol. 2012;2012:648915. [PMID: 22567408 DOI: 10.1155/2012/648915] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
71 Novo E, Parola M. The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2012;5:S4. [PMID: 23259696 DOI: 10.1186/1755-1536-5-S1-S4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
72 Wu L, Mao C, Ming X. Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells. Biomed Res Int. 2016;2016:7478650. [PMID: 27579319 DOI: 10.1155/2016/7478650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
73 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
74 Novo E, Cannito S, Zamara E, Valfrè di Bonzo L, Caligiuri A, Cravanzola C, Compagnone A, Colombatto S, Marra F, Pinzani M. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol. 2007;170:1942-1953. [PMID: 17525262 DOI: 10.2353/ajpath.2007.060887] [Cited by in Crossref: 152] [Cited by in F6Publishing: 145] [Article Influence: 10.9] [Reference Citation Analysis]
75 Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med. 2011;3:69-80. [PMID: 24367223 DOI: 10.2147/hmer.s905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Douglass A, Wallace K, Koruth M, Barelle C, Porter AJ, Wright MC. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol Int 2008;2:405-15. [PMID: 19669316 DOI: 10.1007/s12072-008-9093-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
77 Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, Iredale JP. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology. 2009;49:901-910. [PMID: 19072833 DOI: 10.1002/hep.22701] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
78 Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151-166. [PMID: 33128017 DOI: 10.1038/s41575-020-00372-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 45] [Article Influence: 31.0] [Reference Citation Analysis]
79 Novo E, di Bonzo LV, Cannito S, Colombatto S, Parola M. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis. Int J Biochem Cell Biol 2009;41:2089-93. [PMID: 19782946 DOI: 10.1016/j.biocel.2009.03.010] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
80 Pinzani M, Macias-Barragan J. Update on the pathophysiology of liver fibrosis. Expert Rev Gastroenterol Hepatol 2010;4:459-72. [PMID: 20678019 DOI: 10.1586/egh.10.47] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
81 Uribe CC, Dos Santos de Oliveira F, Grossmann B, Kretzmann NA, Reverbel da Silveira T, Giugliani R, Matte U. Cytotoxic effect of amphotericin B in a myofibroblast cell line. Toxicol In Vitro 2013;27:2105-9. [PMID: 23988732 DOI: 10.1016/j.tiv.2013.08.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
82 Jun JI, Lau LF. Resolution of organ fibrosis. J Clin Invest 2018;128:97-107. [PMID: 29293097 DOI: 10.1172/JCI93563] [Cited by in Crossref: 113] [Cited by in F6Publishing: 57] [Article Influence: 37.7] [Reference Citation Analysis]
83 Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Büttner R, Schölmerich J, Hellerbrand C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res. 2009;19:996-1005. [PMID: 19546889 DOI: 10.1038/cr.2009.73] [Cited by in Crossref: 130] [Cited by in F6Publishing: 135] [Article Influence: 10.8] [Reference Citation Analysis]
84 Gentilini A, Lottini B, Brogi M, Caligiuri A, Cosmi L, Marra F, Pinzani M. Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. Fibrogenesis Tissue Repair 2009;2:1. [PMID: 19183465 DOI: 10.1186/1755-1536-2-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
85 Abdel-Hamid IA, Anis T. Peyronie's disease: perspectives on therapeutic targets. Expert Opin Ther Targets 2011;15:913-29. [PMID: 21492024 DOI: 10.1517/14728222.2011.577419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
86 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
87 Zhang F, Lu Y, Zheng S. Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis. Cell Signal. 2012;24:596-605. [PMID: 22108088 DOI: 10.1016/j.cellsig.2011.11.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
88 De Minicis S, Candelaresi C, Agostinelli L, Taffetani S, Saccomanno S, Rychlicki C, Trozzi L, Marzioni M, Benedetti A, Svegliati-Baroni G. Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution. Liver Int. 2012;32:1574-1584. [PMID: 22938186 DOI: 10.1111/j.1478-3231.2012.02860.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
89 Jia S, Zhou W, Wu J, Liu X, Guo S, Zhang J, Liu S, Ni M, Meng Z, Zhang X, Zeng X, Jing Z. A biomolecular network-based strategy deciphers the underlying molecular mechanisms of Bupleuri Radix/ Curcumae Radix medicine pair in the treatment of hepatitis C. European Journal of Integrative Medicine 2020;33:101043. [DOI: 10.1016/j.eujim.2019.101043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
90 Singh HD, Otano I, Rombouts K, Singh KP, Peppa D, Gill US, Böttcher K, Kennedy PTF, Oben J, Pinzani M, Walczak H, Fusai G, Rosenberg WMC, Maini MK. TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis. Sci Rep 2017;7:5514. [PMID: 28717244 DOI: 10.1038/s41598-017-05845-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
91 Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37-55. [PMID: 30213667 DOI: 10.1016/j.mam.2018.09.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 40.3] [Reference Citation Analysis]
92 Horowitz JC, Thannickal VJ. Mechanisms for the Resolution of Organ Fibrosis. Physiology (Bethesda) 2019;34:43-55. [PMID: 30540232 DOI: 10.1152/physiol.00033.2018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
93 Novo E, Povero D, Busletta C, Paternostro C, di Bonzo LV, Cannito S, Compagnone A, Bandino A, Marra F, Colombatto S. The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. J Pathol. 2012;226:588-597. [PMID: 21959987 DOI: 10.1002/path.3005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
94 Sharma S, Ghufran SM, Ghose S, Biswas S. Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells. Sci Rep 2021;11:3089. [PMID: 33542321 DOI: 10.1038/s41598-021-82381-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C, Shi J, Lu C, Ning B, Zhang J. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int. 2015;35:1234-1243. [PMID: 25142507 DOI: 10.1111/liv.12660] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
96 Mu X, Bellayr I, Walters T, Li Y. Mediators leading to fibrosis - how to measure and control them in tissue engineering. Oper Tech Orthop 2010;20:110-8. [PMID: 20890400 DOI: 10.1053/j.oto.2009.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
97 Rockey DC, Friedman SL. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside. Gastroenterology 2021;160:1502-1520.e1. [PMID: 33529675 DOI: 10.1053/j.gastro.2020.09.065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
98 Zhang C, An R, Bao Y, Meng X, Wang T, Sun H, Pan F, Zhang C. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways. International Immunopharmacology 2019;73:515-26. [DOI: 10.1016/j.intimp.2019.05.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
99 Böttcher K, Pinzani M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv Drug Deliv Rev 2017;121:3-8. [PMID: 28600202 DOI: 10.1016/j.addr.2017.05.016] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
100 刘梅, 李树杰, 李阳, 解瑞金, 汲书生. Fe-NTA诱导的氧应激通过调节Bcl-2家族蛋白及线粒体膜电位影响人肝星状细胞和肝细胞的凋亡. 世界华人消化杂志 2016; 24(25): 3705-3711 [DOI: 10.11569/wcjd.v24.i25.3705] [Reference Citation Analysis]
101 Amoras Eda S, Gomes ST, Freitas FB, Santana BB, Ishak G, de Araújo MT, Demachki S, da Silva Conde SR, de Oliveira Guimarães Ishak M, Ishak R, Vallinoto AC. NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes. PLoS One 2015;10:e0121754. [PMID: 25816145 DOI: 10.1371/journal.pone.0121754] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
102 da Silva CM, Caetano FH, Pereira FDC, Morales MAM, Sakane KK, Moraes KCM. Cellular and molecular effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts on retinoid metabolism in the human hepatic stellate cell LX-2. BMC Complement Altern Med 2019;19:222. [PMID: 31438947 DOI: 10.1186/s12906-019-2591-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
103 Marsillach J, Ferré N, Camps J, Rull A, Beltran R, Joven J. Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats. Mol Cell Biochem. 2008;308:101-109. [PMID: 17938867 DOI: 10.1007/s11010-007-9617-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
104 Langer DA, Das A, Semela D, Kang-Decker N, Hendrickson H, Bronk SF, Katusic ZS, Gores GJ, Shah VH. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology. 2008;47:1983-1993. [PMID: 18459124 DOI: 10.1002/hep.22285] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
105 Pinzani M, Vizzutti F. Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis. 2008;12:901-913, x. [PMID: 18984473 DOI: 10.1016/j.cld.2008.07.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
106 Bian M, He J, Jin H, Lian N, Shao J, Guo Q, Wang S, Zhang F, Zheng S. Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress. Apoptosis 2019;24:905-20. [DOI: 10.1007/s10495-019-01568-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
107 Liu Y, Lui EL, Friedman SL, Li L, Ye T, Chen Y, Poon RT, Wo J, Kok TW, Fan ST. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling. Lab Invest 2009;89:209-21. [PMID: 19114984 DOI: 10.1038/labinvest.2008.127] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
108 Mera K, Uto H, Mawatari S, Ido A, Yoshimine Y, Nosaki T, Oda K, Tabu K, Kumagai K, Tamai T, Moriuchi A, Oketani M, Shimada Y, Hidaka M, Eguchi S, Tsubouchi H. Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. BMC Gastroenterol 2014;14:27. [PMID: 24524410 DOI: 10.1186/1471-230X-14-27] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
109 Elshal M, Abu-elsaad N, El-karef A, Ibrahim TM. The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis. Naunyn-Schmiedeberg's Arch Pharmacol 2015;388:1293-304. [DOI: 10.1007/s00210-015-1157-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Chen G, Wang Y, Li M, Xu T, Wang X, Hong B, Niu Y. Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways. Eur J Pharm Sci 2014;65:21-8. [PMID: 25220584 DOI: 10.1016/j.ejps.2014.09.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
111 Caligiuri A, Bertolani C, Guerra CT, Aleffi S, Galastri S, Trappoliere M, Vizzutti F, Gelmini S, Laffi G, Pinzani M. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology. 2008;47:668-676. [PMID: 18098312 DOI: 10.1002/hep.21995] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 6.5] [Reference Citation Analysis]
112 Oh Y, Park O, Swierczewska M, Hamilton JP, Park JS, Kim TH, Lim SM, Eom H, Jo DG, Lee CE, Kechrid R, Mastorakos P, Zhang C, Hahn SK, Jeon OC, Byun Y, Kim K, Hanes J, Lee KC, Pomper MG, Gao B, Lee S. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells. Hepatology. 2016;64:209-223. [PMID: 26710118 DOI: 10.1002/hep.28432] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
113 Guo CJ, Pan Q, Jiang B, Chen GY, Li DG. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis. 2009;14:1331-1340. [PMID: 19784778 DOI: 10.1007/s10495-009-0401-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
114 Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011;4:391-417. [PMID: 22043231 DOI: 10.1177/1756283x11413002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 71] [Article Influence: 14.1] [Reference Citation Analysis]
115 Zhang JX, Li DQ, He AR, Motwani M, Vasiliou V, Eswaran J, Mishra L, Kumar R. Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases. Hepatology 2012;55:1840-51. [PMID: 22223166 DOI: 10.1002/hep.25566] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]